Premium
Expression of Wnt5a in urothelial carcinoma as potential prognostic marker
Author(s) -
Saling Mark,
Duckett Jordan,
Jenkinson Scott,
Malgor Ramiro
Publication year - 2015
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.29.1_supplement.417.5
Subject(s) - immunohistochemistry , immunostaining , pathology , malignancy , wnt5a , medicine , staining , cancer , bladder cancer , wnt signaling pathway , biology , signal transduction , biochemistry
Bladder cancer is the fourth most common cancer in males and the most common malignancy of the urinary tract. According to American Cancer Society 74,690 new cases and 15,580 deaths from bladder cancer are expected for 2014 in the US. Our group recently reported a positive correlation between the expression of Wnt5a, a member of the Wnt proteins family, and histopathological grade and stage of urothelial carcinoma (UC). The objective of the study was to analyze the correlation between the expression of Wnt5a, E‐cadherin, and β‐catenin and histopathological grade of the UC in human tissue samples. The expression of the receptor tyrosine kinase‐like orphan receptor 2 (Ror2) in the tumor as a mechanism of Wnt5a in the metastatic process was also explored Tissue samples were obtained via transurethral resection for diagnostic purposes, formalin fixed and paraffin embedded. Wnt5a, E‐cadherin, β‐catenin, and Ror‐2 expression was characterized in UC samples using immunohistochemistry (IHC). The histopathological grade of each sample was determined using H&E stained sections and applying International Society of Urological Pathology (ISUP) criteria. The IHC results show that low grade tumors show strong staining for E‐cadherin and β‐catenin and weak staining for Wnt5a while, high grade tumors show opposite result. Interestingly, high grade tumors that show invasion into the muscularis propria show strong immunostaining for both Wnt5a and Ror2 while in noninvasive tumors a weak staining for Ror2 was detected. These results are in agreement with previous reports from our laboratory and support the potential application of Wnt5a as a prognostic marker for UC. Based on our results, Wnt5a‐Ror2 signaling may play a role in the invasiveness of UC.